Jack‐Michel Renoir

Centre National de la Recherche Scientifique — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

43h-index6.0kcitations100works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(33), Heat shock proteins research(22), RNA Interference and Gene Delivery(11), Hormonal and reproductive studies(9), Multiple Myeloma Research and Treatments(8)

Publications100 total

Role of JMJD6 in Breast Tumourigenesis
PLoS ONE·2015· 55 citedOpen Access
Abstract LB-238: Antitumor activity of mini-IGFBP-3, a protease-resistant derivative of human IGF binding protein-3
Cancer Research·2014
Deazaneplanocin A Is a Promising Drug to Kill Multiple Myeloma Cells in Their Niche
PLoS ONE·2014· 10 citedOpen Access
Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors
European Journal of Medicinal Chemistry·2014· 30 cited
Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells
Molecular Oncology·2014· 33 citedOpen Access
Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism
Oncotarget·2013· 28 citedOpen Access
Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism
Europe PMC (PubMed Central)·2013Open Access
4-Hydroxy-tamoxifen-loaded liposomes have potent anti-myeloma activity
Leukemia & lymphoma/Leukemia and lymphoma·2012· 2 cited
Estrogen receptor signaling as a target for novel breast cancer therapeutics
Biochemical Pharmacology·2012· 188 citedOpen Access
Anticancer Drugs in Liposomal Nanodevices: A Target Delivery for a Targeted Therapy
Current Topics in Medicinal Chemistry·2012· 24 citedOpen Access
Estradiol receptors in breast cancer cells: Associated co-factors as targets for new therapeutic approaches
Steroids·2012· 31 cited
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
Endocrine Reviews·2011· 283 citedOpen Access
Cover Picture: Discovery and Biological Activity of 6BrCaQ as an Inhibitor of the Hsp90 Protein Folding Machinery (ChemMedChem 5/2011)
ChemMedChem·2011Open Access
Liposomal trichostatin A: therapeutic potential in hormone-dependent and -independent breast cancer xenograft models
Hormone Molecular Biology and Clinical Investigation·2011· 4 citedOpen Access
Discovery and Biological Activity of 6BrCaQ as an Inhibitor of the Hsp90 Protein Folding Machinery
ChemMedChem·2011· 45 cited
Lipid nanocarriers targeting breast cancers to delivery modulators of estrogens receptors
HAL (Le Centre pour la Communication Scientifique Directe)·2011Open Access
Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy
International Journal of Pharmaceutics·2010· 47 cited
Cyclin K and cyclin D1b are oncogenic in myeloma cells
Molecular Cancer·2010· 18 citedOpen Access
Open Access RESEARCH
2010
Therapeutic Potential of New 4-hydroxy-tamoxifen-Loaded pH-gradient Liposomes in a Multiple Myeloma Experimental Model
Pharmaceutical Research·2009· 18 cited
page 1 of 5Next →

Frequent Co-authors

Véronique Marsaud(19), Christine Radanyi(15), Etienne‐Emile Baulieu(11), Ján Mešter(7), E.E. Baulieu(6), Patrick Couvreur(5), Céline Bouclier(5), Elias Fattal(5), E.E. Baulieu(5), Barbara Stella(4), Luigi Cattel(4), Marie‐Claire Lebeau(4), Lee E. Faber(4), Pentti Tuohimaa(4), Silvia Arpicco(4), Angélique Gougèlet(4), Jean‐François Peyrat(4), Jean‐Daniel Brion(4), Mouâd Alami(4), Thierry Buchou(4)